This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
Its that time of year again! Jade Teakell is leading team #UrineItToWinIt for #HCWvsHunger 2024. Read more.
This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
This week, we will discuss post-trial follow-up for EMPA-Kidney. What are the longer-term effects of empagliflozin for patients with chronic kidney disease?
Episode 045: Switching table salt to a blend of sodium and potassium chloride reduces stroke and improves total mortality. What’s not to like?
The SSASS trial editorial is up in Kidney Medicine! Have a read.
Nice work by Yoshinosuke Shimamura, Michael Turk, Md Abdul Qader and Shweta Shah!
shweta shah did an amazing job on this week’s visual abstract.
